Nantahala Capital Management »

ADC Therapeutics SA shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of ADC Therapeutics SA (ADCT) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in ADC Therapeutics SA

Tip: Access up to 7 years of quarterly data

All positions including ADC Therapeutics SA held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in ADC Therapeutics SA by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $9.1M 2.3M 4.00
2025-06-30 $6.1M 2.3M 2.68
2023-09-30 $231k 257k 0.90
2023-06-30 $1.8M 840k 2.15
2023-03-31 $1.6M 840k 1.95
2022-12-31 $934k 243k 3.84

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Edwards Lifesciences Put Option (EW)
Hilton Grand Vacations (HGV)
Establishment Labs Holdings Ord (ESTA)
Peloton Interactive Cl A Com (PTON)
Spdr Series Trust S&p Biotech Put Option (XBI)
Herbalife Com Shs (HLF)
Soleno Therapeutics (SLNO)
Ban (TBBK)
Uniqure Nv SHS (QURE)
Teva Pharmaceutical Inds Sponsored Ads Call Option (TEVA)
Viatris Call Option (VTRS)
Abivax Sa Sponsored Ads (ABVX)
Xtant Med Hldgs Com New (XTNT)
Fulcrum Therapeutics (FULC)

View all positions for Nantahala Capital Management

Top funds holding ADC Therapeutics SA

Redmile Group
Point72 Asset Management
Prosight Management
OrbiMed Advisors
BlackRock
Morgan Stanley
Nantahala Capital Management
Goldman Sachs Group
TCG Crossover Management
Lynx1 Capital Management
State Street Corporation
Platinum Investment Mangement
Geode Capital Management
Citadel Advisors
Blue Owl Capital Holdings

View all funds holding ADC Therapeutics SA